Formulation including 1 h-quinazolin-2, 4-diona receptor antagonism in the form of immediate release and preparation of 1 h-quinazolin-2, 4-diona including 1 h-quinazolin-2, 4-diona receptor antagonism in FOV
The present invention relates to pharmaceutical formulations comprising a 1H-quinazoline-2,4-dione AMPA receptor antagonist. More particularly, the invention relates to immediate release formulations comprising such a compound.